Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
Jul 14, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 150,000 314.52 - 319.43
Aug 27, 2014 yancopoulos george Officer Option Execute 5,720 314.31
Feb 11, 2014 yancopoulos george Officer Automatic Sell 100,476 314.31
Oct 1, 2013 schleifer leonard s Officer Automatic Sell 20,114 313.58
Mar 21, 2014 sanofi Beneficial Owner (10% or more) Buy 305,115 313.12 - 332.78
Oct 2, 2013 schleifer leonard s Officer Automatic Sell 9,162 312.44 - 317.34
Jul 11, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 150,000 311.39 - 318.72
Jul 7, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 256,700 311.17 - 315.59
Jul 15, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 129,100 310.18 - 319.69
Jul 3, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 100,000 309.46 - 312.84
Jul 8, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 153,000 309.33 - 314.85
Sep 26, 2013 brown michael s Director Automatic Sell 5,000 309.00
Jul 10, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 175,000 306.77 - 314.58
Sep 18, 2013 schleifer leonard s Officer Automatic Sell 115,440 304.38
Sep 18, 2013 vagelos p roy Officer Automatic Sell 167,144 304.38
Mar 7, 2014 sanofi Beneficial Owner (10% or more) Buy 69,873 304.21 - 325.82
Jul 9, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 195,000 304.19 - 311.91
Sep 18, 2013 roberts william Officer Automatic Sell 15,000 304.00
Mar 27, 2014 sanofi Beneficial Owner (10% or more) Buy 306,945 302.96 - 316.49
Sep 30, 2013 baker charles a Director Automatic Sell 15,000 302.46 - 319.13
Showing 121-140 of 952 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)